A negative number isn’t a verdict that your company is worthless. It’s the math telling you something specific about your growth.
You filled in your past financials, your current numbers, and your projections. You were careful. You took your current revenue, grew it several times over across the forecast period, grew your costs to match, and clicked through. Then the report came back with a valuation below zero. A negative number. And your honest first reaction was the right one: “I don’t understand. How can a company be worth less than nothing?”
It can’t. Not in any real sense. If your company were genuinely worth less than zero, the rational move would be to shut it down today and go do something else, because by definition you’d be destroying value by continuing. So a negative valuation is not a statement that the world would be better off without your startup. It’s a mathematical result, an artifact of how the model treats growth and risk, and once you understand what produced it, it turns into one of the more useful signals you can get out of a valuation.
This came up recently from a founder building in EV charging. The numbers were sensible on the surface. The output was not. Here is what was actually going on, and how to read it.
A negative number is real math, not a broken tool
First, let’s be precise, because there’s a lot of confusing material out there. We’re talking about a negative valuation coming out of a discounted cash flow model. That is a different thing from “negative enterprise value,” which is a public-market situation where a listed company holds more cash than its entire market capitalization. If you go searching and land on articles about cash-rich public companies trading below their cash balance, close the tab. It has nothing to do with what your report is showing you. This is also not a down round or a negative signal from investors. It’s a number from a model, and the model is doing exactly what it’s designed to do.
A DCF works by taking the cash a business is expected to produce in the future and discounting it back to today, because money you might earn in five years is worth less than money in hand now. The further out the cash, and the riskier the company, the harder it gets discounted. Most of the value in any early-stage DCF sits in the later years and in the terminal value, the lump that represents everything beyond the explicit forecast.
That terminal value carries most of the weight in the result, which is why so much DCF commentary online fixates on it, usually on the trap where someone assumes a long-term growth rate so high it breaks the terminal-value math. Set that aside. It’s a technicality, but it isn’t your problem here. As a founder you didn’t hand-tune a perpetuity growth rate, you entered revenue, costs, and a forecast.
The reason your number came out negative is more fundamental, and it’s the one your own inputs point to.
Why your specific projections produced it
Here’s the core idea, stated as plainly as we can: a company has to grow fast enough to pay for the risk of the capital it raises. Capital is never free. Every euro an investor puts into your startup is a euro they could have put somewhere else, into another company at the same risk offering a higher return, or into a safer bet offering the same return for less risk. That foregone alternative is the cost of capital, and it’s the bar your cash flows have to clear. If your projected cash flow doesn’t grow fast enough to beat it, the discounted value of those flows doesn’t cover what the capital costs, and the math can land below zero.
Early-stage startups carry a very high cost of risk. In Equidam’s framework, the discount rate for an early-stage company sits around 60 percent annually, easing toward a floor near 48 percent as the company matures. That is an enormous bar. It exists because of where the risk actually lives: around half of new businesses have closed by their five-year mark, and roughly three quarters of venture-backed startups fail. The discount rate is just that failure probability translated into a yearly number. The less de-risked the company, the steeper the rate the cash flow has to beat. You can see the same logic in independent benchmarks that put public companies around 10 percent, predictably scaling private companies near 15 percent, and pre-scale private companies around 20 percent. Early-stage startups sit far above all of those, because they’re far less proven.
Now layer your projections onto that bar. You may well have grown revenue steeply, and you should: the average startup on Equidam forecasts roughly 522 percent revenue growth in its first year, 236 percent in its second, and 136 percent in its third. Fast top-line growth is the norm at this stage, not the exception, so the problem usually isn’t that your revenue line is too timid. It’s the part that quietly does the damage: you grew your costs to match your revenue.
When costs scale in lockstep with revenue, your net cash flow stays flat. The top line moves, the bottom line barely does. And it’s the bottom line, the actual cash the business throws off, that the model discounts. So you’ve handed the DCF a stream of cash flows that grow slowly, if at all, in real terms, and then asked it to discount that stream at one of the highest rates in finance. Discount a slow-growing or flat cash flow hard enough and the early years (when an early-stage company is often burning cash) can outweigh the discounted later years. The sum lands below zero.
That negative number isn’t an insult. It’s the model saying, with no diplomacy whatsoever, your projected growth doesn’t currently outpace the cost of your risk.
How to read it, and how to fix it
The first thing to do is reframe what you’re holding. You don’t have a worthless company. You have a forecast that, as entered, doesn’t clear the bar. That’s a forecasting question, not an existential one, and it’s fixable. Treat the negative as a signal, not a verdict.
Then work through three things, in order.
Revisit the later years of your forecast. Most of a startup’s value lives in the back end of the model and the terminal value, so that’s where changes move the number most. The goal isn’t to fabricate a hockey stick. It’s to ask honestly whether your real plan is steeper than what you typed. Founders who model every year as the same smooth multiple, with costs rising in lockstep, often understate their own trajectory, because they’re ignoring the operating leverage they actually expect once the business finds its footing. If your genuine expectation is that cash flow accelerates in years four and five as the model matures, put that in, and make sure you can defend it line by line. Watch whether the valuation crosses into positive territory as you do.
Check the cost base that’s eating every year. This is the one that caught the EV-charging founder, and it catches a lot of people. Growing costs one-for-one with revenue is a conservative instinct, but it’s also the precise mechanism that flattens net cash flow and keeps it from ever clearing the discount rate. Real businesses get some operating leverage as they scale. Not all costs are variable. If yours are modeled as if every euro of new revenue brings a matching euro of new cost forever, you’ve built a business that’s structurally incapable of producing meaningful cash, and the model will price it accordingly. Look hard at which costs genuinely scale with revenue and which don’t.
Mind the forecast horizon. A very short explicit forecast can cut off the period right when the business was about to turn cash-generative, leaving the model with mostly the cash-burning early years to discount. Make sure your horizon is long enough to actually reach the point where the economics turn.
Make these changes and re-run it. In our experience the number usually moves into positive territory once the cost base and the later-year cash flows reflect the real plan rather than a flat multiple. If it stays stubbornly negative after sensible, defensible revisions, there are two possibilities, and you should be honest about both. One is a data-entry issue, a misplaced figure in past or current financials, a sign error, a unit mismatch, and that’s a fair thing to raise with Equidam support. The other is harder. If the numbers genuinely are right and the valuation is still negative, the model is telling you that this business, as planned, doesn’t earn back the cost of the capital it needs. The future cash flows don’t compensate for the risk you’re asking investors to take. That isn’t a glitch to fix. It’s a signal to take seriously, because a venture that can’t clear its own cost of capital is one where that capital, and your own time, would likely earn more elsewhere. The model isn’t being cruel. It’s surfacing a question about the business itself, not just the spreadsheet.
The deeper point worth keeping
Strip it all back and the lesson is simple. Early-stage companies carry a high cost of risk, and your projections have to clear that bar to show positive value. Growth has to outpace the price of the risk you’re asking capital to take on. A negative valuation is just the math being blunt about a gap between the two.
This is also a good moment to remember that no single method should carry the whole weight at the early stage, which is exactly why a serious valuation blends several. Equidam runs five methods: two qualitative ones that price your risk, and three financial ones, including the DCF variants, that price your return. Early on, when financials are thin and uncertain, the qualitative methods carry more of the weight precisely because a single DCF can swing to extremes like the one you just saw. As the company matures and the numbers firm up, the financial methods take on more weight. A negative DCF in isolation is loud, but it’s one voice in a chorus, and the methodology is built to keep it in proportion.
None of this means the model has handed you the “right” number once it turns positive, either. A valuation is a defensible, methodology-backed estimate, a shared language for talking to investors about what your company might be worth and why. It is not a precise measurement of truth, and any tool that tells you otherwise is overselling. What the negative result gives you is genuinely valuable: a clear, early signal that your growth assumptions and your cost structure don’t yet add up to a business that pays for its own risk. That’s better to learn now, alone with your model, than across the table from an investor.
If you want to see exactly where your own number is coming from, and watch how steeper later-year cash flow or a more realistic cost base moves it, that’s what the model is built to show you. Equidam’s benchmarks draw on 30,000+ public-market comparables, across 90+ countries and 600+ industries, so the discount rate you’re being held against reflects real companies at your stage, not a guess. Adjust the forecast, re-run it, and read the result as what it is: a diagnosis, not a sentence.